BRSYX
Price
$17.00
Change
-$0.09 (-0.53%)
Updated
Jul 31 closing price
Net Assets
318.1M
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

BRSYX vs VSCIX

BRSYX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
BRSYX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRSYX is a Buy and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. BRSYX (318M). VSCIX pays higher dividends than BRSYX: VSCIX (1.23) vs BRSYX (0.65). BRSYX was incepted earlier than VSCIX: BRSYX (11 years) vs VSCIX (29 years). BRSYX (0.77) is less costly to investors than VSCIX (0.03). BRSYX is a more actively managed with annual turnover of: 66.00 vs. VSCIX (17.00). BRSYX has a lower initial minimum investment than VSCIX: BRSYX (0) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 22.58 vs. BRSYX (18.76). VSCIX return over 5 years is better than : 35.13 vs. BRSYX (-0.30).
BRSYXVSCIXBRSYX / VSCIX
Total Expense Ratio0.660.032,200%
Annual Report Gross Expense Ratio0.770.032,567%
Fund Existence11 years29 years-
Gain YTD14.86514.591102%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets318M189B0%
Annual Yield % from dividends0.651.2353%
Returns for 1 year18.7622.5883%
Returns for 3 years19.5843.4445%
Returns for 5 years-0.3035.13-1%
Returns for 10 years68.02156.0744%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C